{
    "2018-01-15": [
        [
            {
                "time": "2023-10-05",
                "original_text": "Foreign Stock Roundup: Infosys Beats; AstraZeneca's Asthma Drug Gets Approval in EU",
                "features": {
                    "keywords": [
                        "Infosys",
                        "Beats",
                        "AstraZeneca",
                        "Asthma Drug",
                        "Approval",
                        "EU"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "technology",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Foreign Stock Roundup: Infosys Beats; AstraZeneca's Asthma Drug Gets Approval in EU",
                "features": {
                    "keywords": [
                        "Infosys",
                        "Beats",
                        "AstraZeneca",
                        "Asthma Drug",
                        "Approval",
                        "EU"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "technology",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}